Paireder, M., Jomrich, G., Kristo, I., Asari, R., Rieder, E., Beer, A., . . . Schoppmann, S. F. (2020). Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity. Strahlenther Onkol.
Chicago Style CitationPaireder, Matthias, et al. "Modification of Preoperative Radiochemotherapy for Esophageal Cancer (CROSS Protocol) Is Safe and Efficient With No Impact On Surgical Morbidity." Strahlenther Onkol 2020.
MLA CitationPaireder, Matthias, et al. "Modification of Preoperative Radiochemotherapy for Esophageal Cancer (CROSS Protocol) Is Safe and Efficient With No Impact On Surgical Morbidity." Strahlenther Onkol 2020.
Warning: These citations may not always be 100% accurate.